Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
Brazil
/
Healthcare
/
Fleury
FLRY3
Fleury
Aging Population And AI Will Redefine Preventive Healthcare
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 11 Analysts
Published
27 Jul 25
Updated
21 Aug 25
0
Set Fair Value
0
votes
Share
AnalystHighTarget
's Fair Value
R$19.50
27.1% undervalued
intrinsic discount
21 Aug
R$14.21
Loading
1Y
-11.2%
7D
0.9%
Author's Valuation
R$19.5
27.1% undervalued
intrinsic discount
AnalystHighTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystHighTarget Fair Value
R$19.5
27.1% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
0
10b
2014
2017
2020
2023
2025
2026
2028
Revenue R$9.8b
Earnings R$1.1b
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
6.12%
Healthcare Services revenue growth rate
0.26%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
17.80%
Calculation
R$1.06b
Earnings '28
x
16.47x
PE Ratio '28
=
R$17.44b
Market Cap '28
R$17.44b
Market Cap '28
/
547.23m
No. shares '28
=
R$31.86
Share Price '28
R$31.86
Share Price '28
Discounted to 2025 @ 17.80% p.a.
=
R$19.49
Fair Value '25